SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 270,004.69 |
Enterprise Value ($M) | 288,068.69 |
Book Value ($M) | 44,524.00 |
Book Value / Share | 17.54 |
Price / Book | 6.06 |
NCAV ($M) | -27,380.00 |
NCAV / Share | -10.79 |
Price / NCAV | -9.86 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | 0.19 |
Return on Assets (ROA) | 0.14 |
Return on Equity (ROE) | 0.38 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.23 |
Current Ratio | 1.47 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 35,722.00 |
Assets | 109,160.00 |
Liabilities | 63,102.00 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 59,283.00 |
Operating Income | 22,801.00 |
Net Income | 14,519.00 |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 19,095.00 |
Cash from Investing | -4,960.00 |
Cash from Financing | -9,119.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Vanguard Group Inc | 8.96 | 7.58 | |
13G/A | BlackRock Inc. | 8.50 | 8.47 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
581,314 | 3,935,547 | 14.77 | |
552,862 | 3,845,182 | 14.38 | |
444,471 | 4,326,614 | 10.27 | |
720,676 | 4,413,460 | 16.33 | |
632,113 | 5,276,643 | 11.98 | |
(click for more detail) |
Similar Companies | |
---|---|
JNJ – Johnson & Johnson | LCI – Lannett Company, Inc. |
LLY – Eli Lilly And Co | MYOV – Myovant Sciences Ltd. |
NUVB – Nuvation Bio Inc |